In combination with AFP and abdominal ultrasound serum biomarkers might improve HCC screening and increase early diagnosis, although further validation studies are required to confirm their clinical performance in predicting and/or detecting HCC. The gene discussed is AFP; the disease is hepatocellular carcinoma.